These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 20031717)

  • 1. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.
    Yokoyama S; Takano M; Yamamoto M; Inami S; Sakai S; Okamatsu K; Okuni S; Seimiya K; Murakami D; Ohba T; Uemura R; Seino Y; Hata N; Mizuno K
    Circ Cardiovasc Interv; 2009 Jun; 2(3):205-12. PubMed ID: 20031717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
    Ueda Y; Matsuo K; Nishimoto Y; Sugihara R; Hirata A; Nemoto T; Okada M; Murakami A; Kashiwase K; Kodama K
    JACC Cardiovasc Interv; 2015 May; 8(6):814-821. PubMed ID: 25999104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries.
    Shinke T; Li J; Chen JP; Pendyala L; Goodchild T; Jabara R; Geva S; Ueno T; Chronos N; Robinson K; Hou D
    Circ Cardiovasc Interv; 2008 Aug; 1(1):28-35. PubMed ID: 20031652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Yamamoto M; Takano M; Murakami D; Inami T; Kobayashi N; Inami S; Okamatsu K; Ohba T; Ibuki C; Hata N; Seino Y; Jang IK; Mizuno K
    Am Heart J; 2011 Jun; 161(6):1200-6. PubMed ID: 21641369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
    Andreou I; Takahashi S; Tsuda M; Shishido K; Antoniadis AP; Papafaklis MI; Mizuno S; Coskun AU; Saito S; Feldman CL; Edelman ER; Stone PH
    Atherosclerosis; 2016 Sep; 252():9-14. PubMed ID: 27494445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary angioscopic evaluation for serial changes of luminal appearance after pharmacological and catheter interventions.
    Takano M; Mizuno K
    Circ J; 2010 Feb; 74(2):240-5. PubMed ID: 20019412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bare metal stent implantation for in-stent restenosis with a drug-eluting stent.
    Matsuoka H; Kawakami H; Ohshita A; Kohno T; Shigemi S; Okayama H; Higaki J
    J Cardiol; 2010 Jan; 55(1):135-8. PubMed ID: 20122561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.